Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-24-029971.pdf
0001415889-24-029971.rtf
0001415889-24-029971.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-24-029970.pdf
0001415889-24-029970.rtf
0001415889-24-029970.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001966249-24-000024.pdf
0001966249-24-000024.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-24-016357.pdf
0001558370-24-016357.rtf
0001558370-24-016357.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-24-029518.pdf
0001415889-24-029518.rtf
0001415889-24-029518.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-24-009763.pdf
0001950047-24-009763.rtf
0001950047-24-009763.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-24-028171.pdf
0001415889-24-028171.rtf
0001415889-24-028171.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-24-028012.pdf
0001415889-24-028012.rtf
0001415889-24-028012.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-24-009239.pdf
0001950047-24-009239.rtf
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001968582-24-001081.pdf
0001968582-24-001081.rtf